The Selenium (Se) status could be an important modifiable factor in critically ill patient
outcomes due to the important role of this mineral in several functions. Although there are many
clinical trials with Se interventions in the literature, the evidence is not sufficient to establish a
common criterion regarding the Se status. Background and aims: An analysis was made of the
evolution of selenium (Se) and antioxidant status in critically ill patients with Systemic Inflammatory
Response Syndrome (SIRS) over 7 days of staying in the Intensive Care Unit (ICU). Methods: A
prospective analytical study was carried out on 65 critically ill patients aged 31–77 years. A healthy
control group of 56 volunteers from the same region was recruited to allow comparisons with
reference normal values. The selenium levels in both the plasma and erythrocytes were analyzed
by Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Glutathione Peroxidase (GPx) and
Superoxide Dismutase (SOD) activity and the Total Antioxidant Capacity (TAC) were measured
using kinetic colorimetric methods. Results: Low erythrocyte and plasma Se levels were found at
ICU admission in comparison with the healthy reference group (p < 0.001), and the levels further
decreased after one week (p < 0.001). Smaller changes in the plasma Se levels were associated with
greater changes in the Sequential Organ Failure Assessment (SOFA) score (p < 0.05). The GPx activity
in the critically ill was lower than in the control group (p < 0.05), with an inverse correlation to the
severity scores at the baseline (p < 0.05) and reaching normal values after one week (p < 0.05). SOD
activity was directly correlated to TAC (p = 0.03), with both parameters exhibiting a direct correlation
to albumin (p < 0.05) after 7 days of ICU stay. Conclusions: A deficient Se status was observed at ICU
admission and worsened further over follow-up regardless of the evolution of the patient severity
and the antioxidant parameters. Adequate Se support from the start of admission could preserve and
contribute to improve the Se-related outcomes and critical patient recovery during longer periods in
the ICU